CNIPA.AI
返回搜索
档案

CARDIAC VALVE WITH EARLY PREFERENTIAL POLARIZATION TOWARDS AN M2 PHENOTYPE POST-IMPLANTATION, AND METHOD OF IMPLANTATION

发明专利审中
1浏览
19权利要求 · 3 独立
§ Ⅰ

卷宗概要

发明人

Derrick Johns; Joseph J. Crudden

IPC 分类

A61F 2/24A61L 27/44

CPC 分类

A61F2/24A61L27/446A61F2210/71A61F2250/67A61L2300/25A61L2400/18A61L2430/20

Cardiac replacement valves that are anti-biofilm and tissue-integrating implantable biomaterial devices that optionally can elute therapeutic ions such as magnesium, silver, copper and/or zinc. In certain embodiments, the devices are hydrophilic due to the presence of ceramic particles such as zeolite. In certain embodiments, the devices are subjected to a surface treatment such as a plasma treatment or a corona discharge treatment to enhance the immobilization of integrin-stimulating peptides such as RGD to the biomaterial for cell adhesion enhancement when implanted in a host. Methods of replacing diseased valves in a patient are also disclosed.

原文(中文)

Cardiac replacement valves that are anti-biofilm and tissue-integrating implantable biomaterial devices that optionally can elute therapeutic ions such as magnesium, silver, copper and/or zinc. In certain embodiments, the devices are hydrophilic due to the presence of ceramic particles such as zeolite. In certain embodiments, the devices are subjected to a surface treatment such as a plasma treatment or a corona discharge treatment to enhance the immobilization of integrin-stimulating peptides such as RGD to the biomaterial for cell adhesion enhancement when implanted in a host. Methods of replacing diseased valves in a patient are also disclosed.